ID   BCL2_MOUSE              Reviewed;         236 AA.
AC   P10417; P10418; Q4VBF6;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2012, sequence version 3.
DT   18-JUN-2025, entry version 232.
DE   RecName: Full=Apoptosis regulator Bcl-2;
GN   Name=Bcl2; Synonyms=Bcl-2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS ALPHA AND BETA).
RC   STRAIN=BALB/cJ; TISSUE=Liver;
RX   PubMed=3032455; DOI=10.1016/0092-8674(87)90448-x;
RA   Negrini M., Silini E., Kozak C., Tsujimoto Y., Croce C.M.;
RT   "Molecular analysis of mbcl-2: structure and expression of the murine gene
RT   homologous to the human gene involved in follicular lymphoma.";
RL   Cell 49:455-463(1987).
RN   [2]
RP   SEQUENCE REVISION TO 221-222.
RX   PubMed=1508712; DOI=10.1093/nar/20.16.4187;
RA   Eguchi Y., Ewert D.L., Tsujimoto Y.;
RT   "Isolation and characterization of the chicken bcl-2 gene: expression in a
RT   variety of tissues including lymphoid and neuronal organs in adult and
RT   embryo.";
RL   Nucleic Acids Res. 20:4187-4192(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Olfactory epithelium;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION AT SER-70 BY PKC, AND MUTAGENESIS OF SER-70.
RX   PubMed=9115213; DOI=10.1074/jbc.272.18.11671;
RA   Ito T., Deng X., Carr B., May W.S. Jr.;
RT   "Bcl-2 phosphorylation required for anti-apoptosis function.";
RL   J. Biol. Chem. 272:11671-11673(1997).
RN   [7]
RP   DEPHOSPHORYLATION BY PP2A.
RX   PubMed=9852076; DOI=10.1074/jbc.273.51.34157;
RA   Deng X., Ito T., Carr B., Mumby M., May W.S. Jr.;
RT   "Reversible phosphorylation of Bcl2 following interleukin 3 or bryostatin 1
RT   is mediated by direct interaction with protein phosphatase 2A.";
RL   J. Biol. Chem. 273:34157-34163(1998).
RN   [8]
RP   INTERACTION WITH EI24.
RX   PubMed=15781622; DOI=10.1158/0008-5472.can-04-3377;
RA   Zhao X., Ayer R.E., Davis S.L., Ames S.J., Florence B., Torchinsky C.,
RA   Liou J.S., Shen L., Spanjaard R.A.;
RT   "Apoptosis factor EI24/PIG8 is a novel endoplasmic reticulum-localized Bcl-
RT   2-binding protein which is associated with suppression of breast cancer
RT   invasiveness.";
RL   Cancer Res. 65:2125-2129(2005).
RN   [9]
RP   INTERACTION WITH GIMAP3; GIMAP4 AND GIMAP5.
RX   PubMed=16509771; DOI=10.1371/journal.pbio.0040103;
RA   Nitta T., Nasreen M., Seike T., Goji A., Ohigashi I., Miyazaki T., Ohta T.,
RA   Kanno M., Takahama Y.;
RT   "IAN family critically regulates survival and development of T
RT   lymphocytes.";
RL   PLoS Biol. 4:593-605(2006).
RN   [10]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=17418785; DOI=10.1016/j.cell.2007.01.045;
RA   Bruey J.M., Bruey-Sedano N., Luciano F., Zhai D., Balpai R., Xu C.,
RA   Kress C.L., Bailly-Maitre B., Li X., Osterman A., Matsuzawa S.,
RA   Terskikh A.V., Faustin B., Reed J.C.;
RT   "Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by
RT   interaction with NALP1.";
RL   Cell 129:45-56(2007).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Lung, and Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [12]
RP   INTERACTION WITH GIMAP5.
RX   PubMed=21502331; DOI=10.1084/jem.20101192;
RA   Chen Y., Yu M., Dai X., Zogg M., Wen R., Weiler H., Wang D.;
RT   "Critical role for Gimap5 in the survival of mouse hematopoietic stem and
RT   progenitor cells.";
RL   J. Exp. Med. 208:923-935(2011).
RN   [13]
RP   SUBCELLULAR LOCATION.
RX   PubMed=29020630; DOI=10.1016/j.celrep.2017.09.052;
RA   Edison N., Curtz Y., Paland N., Mamriev D., Chorubczyk N.,
RA   Haviv-Reingewertz T., Kfir N., Morgenstern D., Kupervaser M., Kagan J.,
RA   Kim H.T., Larisch S.;
RT   "Degradation of Bcl-2 by XIAP and ARTS Promotes Apoptosis.";
RL   Cell Rep. 21:442-454(2017).
CC   -!- FUNCTION: Suppresses apoptosis in a variety of cell systems including
CC       factor-dependent lymphohematopoietic and neural cells. Regulates cell
CC       death by controlling the mitochondrial membrane permeability. Appears
CC       to function in a feedback loop system with caspases. Inhibits caspase
CC       activity either by preventing the release of cytochrome c from the
CC       mitochondria and/or by binding to the apoptosis-activating factor
CC       (APAF-1). Also acts as an inhibitor of autophagy: interacts with BECN1
CC       and AMBRA1 during non-starvation conditions and inhibits their
CC       autophagy function (By similarity). May attenuate inflammation by
CC       impairing NLRP1-inflammasome activation, hence CASP1 activation and
CC       IL1B release (PubMed:17418785). {ECO:0000250|UniProtKB:P10415,
CC       ECO:0000269|PubMed:17418785}.
CC   -!- SUBUNIT: Forms homodimers, and heterodimers with BAX, BAD, BAK and Bcl-
CC       X(L). Heterodimerization with BAX requires intact BH1 and BH2 motifs,
CC       and is necessary for anti-apoptotic activity (By similarity). Component
CC       of the complex, at least composed of LRPPRC, BECN1 and BCL2; the
CC       interactions prevent BECN1 from forming an autophagy-inducing complex
CC       with PIK3C3 (By similarity). Also interacts with APAF1, BBC3, BCL2L1,
CC       BNIPL, MRPL41 and TP53BP2. Binding to FKBP8 seems to target BCL2 to the
CC       mitochondria and probably interferes with the binding of BCL2 to its
CC       targets. Interacts with BAG1 in an ATP-dependent manner. Interacts with
CC       RAF1 (the 'Ser-338' and 'Ser-339' phosphorylated form). Interacts (via
CC       the BH4 domain) with EGLN3; the interaction prevents the formation of
CC       the BAX-BCL2 complex and inhibits the anti-apoptotic activity of BCL2
CC       (By similarity). Interacts with EI24. Interacts with G0S2; this
CC       interaction also prevents the formation of the anti-apoptotic BAX-BCL2
CC       complex. Interacts with PPIF; the interaction is impaired by CsA (By
CC       similarity). Interacts with BOP (By similarity). Interacts with the
CC       SCF(FBXO10) complex (By similarity). Interacts (via the loop between
CC       motifs BH4 and BH3) with NLRP1 (via LRR repeats) (By similarity).
CC       Interacts with GIMAP3/IAN4 and GIMAP4/IAN1 (PubMed:16509771). Also
CC       interacts with GIMAP5/IAN5 (PubMed:16509771, PubMed:21502331).
CC       Interacts with BCAP31 (By similarity). Interacts with IRF3 (By
CC       similarity). Interacts with BECN1; thereby inhibiting autophagy in non-
CC       starvation conditions (By similarity). Interacts with AMBRA1; thereby
CC       inhibiting autophagy (By similarity). {ECO:0000250|UniProtKB:P10415,
CC       ECO:0000269|PubMed:16509771, ECO:0000269|PubMed:21502331}.
CC   -!- INTERACTION:
CC       P10417; Q07813: Bax; NbExp=2; IntAct=EBI-526314, EBI-700711;
CC       P10417; O54918-1: Bcl2l11; NbExp=2; IntAct=EBI-526314, EBI-526076;
CC       P10417; O88597: Becn1; NbExp=11; IntAct=EBI-526314, EBI-643716;
CC       P10417; Q99MI6: Gimap3; NbExp=4; IntAct=EBI-526314, EBI-15572304;
CC       P10417; Q8BWF2: Gimap5; NbExp=3; IntAct=EBI-526314, EBI-15572348;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane
CC       {ECO:0000250|UniProtKB:P10415}; Single-pass membrane protein
CC       {ECO:0000255}. Nucleus membrane {ECO:0000250|UniProtKB:P10415}; Single-
CC       pass membrane protein {ECO:0000255}. Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:P10415}; Single-pass membrane protein
CC       {ECO:0000255}. Cytoplasm {ECO:0000269|PubMed:29020630}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Alpha;
CC         IsoId=P10417-1; Sequence=Displayed;
CC       Name=Beta;
CC         IsoId=P10417-2; Sequence=VSP_000513;
CC   -!- TISSUE SPECIFICITY: Expressed in a variety of tissues.
CC   -!- DOMAIN: The BH4 motif is required for anti-apoptotic activity and for
CC       interaction with RAF1 and EGLN3.
CC   -!- DOMAIN: BH1 and BH2 domains are required for the interaction with BAX
CC       and for anti-apoptotic activity. {ECO:0000250|UniProtKB:P10415}.
CC   -!- DOMAIN: The loop between motifs BH4 and BH3 is required for the
CC       interaction with NLRP1. {ECO:0000250|UniProtKB:P10415}.
CC   -!- DOMAIN: The BH3 motif is required for XIAP-mediated ubiquitination and
CC       subsequent induction of apoptosis. {ECO:0000250|UniProtKB:P10415}.
CC   -!- PTM: Phosphorylation/dephosphorylation on Ser-70 regulates anti-
CC       apoptotic activity (PubMed:9115213). Growth factor-stimulated
CC       phosphorylation on Ser-70 by PKC is required for the anti-apoptosis
CC       activity and occurs during the G2/M phase of the cell cycle
CC       (PubMed:9115213). In the absence of growth factors, BCL2 appears to be
CC       phosphorylated by other protein kinases such as ERKs and stress-
CC       activated kinases (PubMed:9115213). Phosphorylated by MAPK8/JNK1 at
CC       Thr-69, Ser-70 and Ser-84, which stimulates starvation-induced
CC       autophagy (By similarity). Dephosphorylated by protein phosphatase 2A
CC       (PP2A) (PubMed:9852076). {ECO:0000250|UniProtKB:P10415,
CC       ECO:0000269|PubMed:9115213, ECO:0000269|PubMed:9852076}.
CC   -!- PTM: Proteolytically cleaved by caspases during apoptosis. The cleaved
CC       protein, lacking the BH4 motif, has pro-apoptotic activity, causes the
CC       release of cytochrome c into the cytosol promoting further caspase
CC       activity. {ECO:0000250|UniProtKB:P10415}.
CC   -!- PTM: Monoubiquitinated by PRKN, leading to an increase in its stability
CC       (By similarity). Ubiquitinated by SCF(FBXO10), leading to its
CC       degradation by the proteasome (By similarity).
CC       {ECO:0000250|UniProtKB:P10415}.
CC   -!- DISRUPTION PHENOTYPE: In response to intraperitoneal injection of
CC       muramyl dipeptide (MDP), knockout animals show lower serum IL1B levels
CC       than wild type. Mutant macrophages release 30% less IL1B than the wild-
CC       type cells. {ECO:0000269|PubMed:17418785}.
CC   -!- SIMILARITY: Belongs to the Bcl-2 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L31532; AAA37282.1; -; Genomic_DNA.
DR   EMBL; M16506; AAA37282.1; JOINED; Genomic_DNA.
DR   EMBL; M16506; AAA37281.1; -; Genomic_DNA.
DR   EMBL; AC122842; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC162916; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH466520; EDL39862.1; -; Genomic_DNA.
DR   EMBL; BC095964; AAH95964.1; -; mRNA.
DR   CCDS; CCDS15209.1; -. [P10417-1]
DR   CCDS; CCDS78667.1; -. [P10417-2]
DR   PIR; A25960; TVMSA1.
DR   PIR; B25960; TVMSB1.
DR   RefSeq; NP_033871.2; NM_009741.5. [P10417-1]
DR   RefSeq; NP_803129.2; NM_177410.3. [P10417-2]
DR   AlphaFoldDB; P10417; -.
DR   SMR; P10417; -.
DR   BioGRID; 198318; 33.
DR   ComplexPortal; CPX-2017; BCL-2 dimer.
DR   ComplexPortal; CPX-2019; BAD:BCL-2 complex.
DR   ComplexPortal; CPX-2024; BID:BCL-2 complex.
DR   ComplexPortal; CPX-2027; PUMA:BCL-2 complex.
DR   ComplexPortal; CPX-2036; BIM:BCL-2 complex.
DR   CORUM; P10417; -.
DR   DIP; DIP-1065N; -.
DR   FunCoup; P10417; 1418.
DR   IntAct; P10417; 10.
DR   MINT; P10417; -.
DR   STRING; 10090.ENSMUSP00000108371; -.
DR   BindingDB; P10417; -.
DR   ChEMBL; CHEMBL3309111; -.
DR   GlyGen; P10417; 1 site.
DR   iPTMnet; P10417; -.
DR   PhosphoSitePlus; P10417; -.
DR   PaxDb; 10090-ENSMUSP00000108371; -.
DR   PeptideAtlas; P10417; -.
DR   ProteomicsDB; 273655; -. [P10417-1]
DR   ProteomicsDB; 273656; -. [P10417-2]
DR   Pumba; P10417; -.
DR   Antibodypedia; 3491; 3945 antibodies from 60 providers.
DR   DNASU; 12043; -.
DR   Ensembl; ENSMUST00000112751.2; ENSMUSP00000108371.2; ENSMUSG00000057329.8. [P10417-1]
DR   Ensembl; ENSMUST00000189999.2; ENSMUSP00000139856.2; ENSMUSG00000057329.8. [P10417-2]
DR   GeneID; 12043; -.
DR   KEGG; mmu:12043; -.
DR   UCSC; uc007cgw.2; mouse. [P10417-1]
DR   AGR; MGI:88138; -.
DR   CTD; 596; -.
DR   MGI; MGI:88138; Bcl2.
DR   VEuPathDB; HostDB:ENSMUSG00000057329; -.
DR   eggNOG; KOG4728; Eukaryota.
DR   GeneTree; ENSGT01130000278332; -.
DR   HOGENOM; CLU_085401_0_0_1; -.
DR   InParanoid; P10417; -.
DR   OMA; IAVWMTE; -.
DR   OrthoDB; 6021377at2759; -.
DR   PhylomeDB; P10417; -.
DR   Reactome; R-MMU-111447; Activation of BAD and translocation to mitochondria.
DR   Reactome; R-MMU-111453; BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members.
DR   Reactome; R-MMU-844455; The NLRP1 inflammasome.
DR   BioGRID-ORCS; 12043; 6 hits in 82 CRISPR screens.
DR   ChiTaRS; Bcl2; mouse.
DR   PRO; PR:P10417; -.
DR   Proteomes; UP000000589; Chromosome 1.
DR   RNAct; P10417; protein.
DR   Bgee; ENSMUSG00000057329; Expressed in epithelium of cochlear duct and 231 other cell types or tissues.
DR   ExpressionAtlas; P10417; baseline and differential.
DR   GO; GO:0097138; C:BAD-BCL-2 complex; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:MGI.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:MGI.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:MGI.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0031966; C:mitochondrial membrane; IDA:MGI.
DR   GO; GO:0005741; C:mitochondrial outer membrane; ISS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:MGI.
DR   GO; GO:0043209; C:myelin sheath; IDA:MGI.
DR   GO; GO:0031965; C:nuclear membrane; IDA:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0046930; C:pore complex; IEA:Ensembl.
DR   GO; GO:0051434; F:BH3 domain binding; IEA:Ensembl.
DR   GO; GO:0015267; F:channel activity; IEA:Ensembl.
DR   GO; GO:0016248; F:channel inhibitor activity; IEA:Ensembl.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0060090; F:molecular adaptor activity; IDA:UniProt.
DR   GO; GO:0002020; F:protease binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0051721; F:protein phosphatase 2A binding; IDA:MGI.
DR   GO; GO:0019903; F:protein phosphatase binding; IDA:MGI.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IEA:Ensembl.
DR   GO; GO:0007015; P:actin filament organization; IMP:MGI.
DR   GO; GO:0009887; P:animal organ morphogenesis; IMP:MGI.
DR   GO; GO:0008637; P:apoptotic mitochondrial changes; IDA:MGI.
DR   GO; GO:0006915; P:apoptotic process; IMP:MGI.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0031103; P:axon regeneration; IDA:MGI.
DR   GO; GO:0007409; P:axonogenesis; IMP:MGI.
DR   GO; GO:0001783; P:B cell apoptotic process; IDA:MGI.
DR   GO; GO:0030183; P:B cell differentiation; IMP:MGI.
DR   GO; GO:0001782; P:B cell homeostasis; IMP:MGI.
DR   GO; GO:0002326; P:B cell lineage commitment; IMP:MGI.
DR   GO; GO:0042100; P:B cell proliferation; ISO:MGI.
DR   GO; GO:0050853; P:B cell receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0001662; P:behavioral fear response; IMP:MGI.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; IDA:MGI.
DR   GO; GO:0060402; P:calcium ion transport into cytosol; IGI:MGI.
DR   GO; GO:0043375; P:CD8-positive, alpha-beta T cell lineage commitment; IMP:MGI.
DR   GO; GO:0016477; P:cell migration; IMP:MGI.
DR   GO; GO:0000902; P:cell morphogenesis; IDA:MGI.
DR   GO; GO:0008283; P:cell population proliferation; IGI:MGI.
DR   GO; GO:0098609; P:cell-cell adhesion; IMP:MGI.
DR   GO; GO:0042149; P:cellular response to glucose starvation; IDA:MGI.
DR   GO; GO:0071456; P:cellular response to hypoxia; IDA:MGI.
DR   GO; GO:0021747; P:cochlear nucleus development; IMP:MGI.
DR   GO; GO:0051607; P:defense response to virus; IEA:Ensembl.
DR   GO; GO:0097048; P:dendritic cell apoptotic process; IDA:MGI.
DR   GO; GO:0048589; P:developmental growth; IMP:MGI.
DR   GO; GO:0048066; P:developmental pigmentation; IMP:MGI.
DR   GO; GO:0048546; P:digestive tract morphogenesis; IMP:MGI.
DR   GO; GO:0043583; P:ear development; IMP:MGI.
DR   GO; GO:0032469; P:endoplasmic reticulum calcium ion homeostasis; IGI:MGI.
DR   GO; GO:1904019; P:epithelial cell apoptotic process; IMP:MGI.
DR   GO; GO:0051649; P:establishment of localization in cell; IGI:MGI.
DR   GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IGI:MGI.
DR   GO; GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; ISO:MGI.
DR   GO; GO:0048041; P:focal adhesion assembly; IMP:MGI.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; IMP:MGI.
DR   GO; GO:0022612; P:gland morphogenesis; IMP:MGI.
DR   GO; GO:0032835; P:glomerulus development; IMP:MGI.
DR   GO; GO:0031069; P:hair follicle morphogenesis; IMP:UniProtKB.
DR   GO; GO:0060218; P:hematopoietic stem cell differentiation; IMP:MGI.
DR   GO; GO:0030097; P:hemopoiesis; IMP:MGI.
DR   GO; GO:0048873; P:homeostasis of number of cells within a tissue; IMP:MGI.
DR   GO; GO:0002520; P:immune system development; IMP:MGI.
DR   GO; GO:0006874; P:intracellular calcium ion homeostasis; IDA:MGI.
DR   GO; GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IGI:MGI.
DR   GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; ISS:MGI.
DR   GO; GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; IMP:MGI.
DR   GO; GO:0001822; P:kidney development; IMP:MGI.
DR   GO; GO:0001776; P:leukocyte homeostasis; IMP:MGI.
DR   GO; GO:0070227; P:lymphocyte apoptotic process; IMP:MGI.
DR   GO; GO:0002260; P:lymphocyte homeostasis; IMP:MGI.
DR   GO; GO:0002320; P:lymphoid progenitor cell differentiation; IMP:MGI.
DR   GO; GO:0008584; P:male gonad development; IGI:MGI.
DR   GO; GO:0006582; P:melanin metabolic process; IMP:MGI.
DR   GO; GO:0030318; P:melanocyte differentiation; IMP:MGI.
DR   GO; GO:0014031; P:mesenchymal cell development; IMP:MGI.
DR   GO; GO:0001656; P:metanephros development; IMP:MGI.
DR   GO; GO:0000278; P:mitotic cell cycle; IDA:MGI.
DR   GO; GO:0097049; P:motor neuron apoptotic process; IDA:MGI.
DR   GO; GO:0033028; P:myeloid cell apoptotic process; IDA:MGI.
DR   GO; GO:2000811; P:negative regulation of anoikis; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:MGI.
DR   GO; GO:2001234; P:negative regulation of apoptotic signaling pathway; IDA:MGI.
DR   GO; GO:0010507; P:negative regulation of autophagy; IDA:UniProt.
DR   GO; GO:0002903; P:negative regulation of B cell apoptotic process; IDA:MGI.
DR   GO; GO:0010523; P:negative regulation of calcium ion transport into cytosol; IGI:MGI.
DR   GO; GO:0030308; P:negative regulation of cell growth; IMP:MGI.
DR   GO; GO:0030336; P:negative regulation of cell migration; IMP:MGI.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IMP:MGI.
DR   GO; GO:0032848; P:negative regulation of cellular pH reduction; IEA:Ensembl.
DR   GO; GO:2000669; P:negative regulation of dendritic cell apoptotic process; IDA:MGI.
DR   GO; GO:1904036; P:negative regulation of epithelial cell apoptotic process; IMP:MGI.
DR   GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; ISO:MGI.
DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IDA:MGI.
DR   GO; GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:0070229; P:negative regulation of lymphocyte apoptotic process; IMP:MGI.
DR   GO; GO:0045930; P:negative regulation of mitotic cell cycle; IDA:MGI.
DR   GO; GO:2000672; P:negative regulation of motor neuron apoptotic process; IDA:MGI.
DR   GO; GO:0033033; P:negative regulation of myeloid cell apoptotic process; IDA:MGI.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IDA:MGI.
DR   GO; GO:0030279; P:negative regulation of ossification; IMP:MGI.
DR   GO; GO:0033689; P:negative regulation of osteoblast proliferation; IMP:MGI.
DR   GO; GO:0046671; P:negative regulation of retinal cell programmed cell death; IMP:MGI.
DR   GO; GO:0070233; P:negative regulation of T cell apoptotic process; IDA:MGI.
DR   GO; GO:0051402; P:neuron apoptotic process; IDA:MGI.
DR   GO; GO:0042551; P:neuron maturation; IMP:MGI.
DR   GO; GO:0048599; P:oocyte development; IMP:MGI.
DR   GO; GO:0035265; P:organ growth; IMP:MGI.
DR   GO; GO:0001503; P:ossification; IMP:MGI.
DR   GO; GO:0033687; P:osteoblast proliferation; IMP:MGI.
DR   GO; GO:0001541; P:ovarian follicle development; IMP:MGI.
DR   GO; GO:0048753; P:pigment granule organization; IMP:MGI.
DR   GO; GO:0043473; P:pigmentation; IMP:UniProtKB.
DR   GO; GO:0030890; P:positive regulation of B cell proliferation; IEA:Ensembl.
DR   GO; GO:0030307; P:positive regulation of cell growth; ISO:MGI.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IDA:UniProtKB.
DR   GO; GO:0048087; P:positive regulation of developmental pigmentation; IGI:MGI.
DR   GO; GO:0045636; P:positive regulation of melanocyte differentiation; IMP:MGI.
DR   GO; GO:0040018; P:positive regulation of multicellular organism growth; IMP:MGI.
DR   GO; GO:0014042; P:positive regulation of neuron maturation; IMP:MGI.
DR   GO; GO:0048743; P:positive regulation of skeletal muscle fiber development; IMP:MGI.
DR   GO; GO:0014911; P:positive regulation of smooth muscle cell migration; IMP:MGI.
DR   GO; GO:0009791; P:post-embryonic development; IMP:MGI.
DR   GO; GO:0000209; P:protein polyubiquitination; ISO:MGI.
DR   GO; GO:0072593; P:reactive oxygen species metabolic process; IMP:MGI.
DR   GO; GO:0042981; P:regulation of apoptotic process; IGI:MGI.
DR   GO; GO:0010506; P:regulation of autophagy; IMP:CACAO.
DR   GO; GO:0051924; P:regulation of calcium ion transport; ISO:MGI.
DR   GO; GO:0051726; P:regulation of cell cycle; IMP:MGI.
DR   GO; GO:0001952; P:regulation of cell-matrix adhesion; IMP:MGI.
DR   GO; GO:0048070; P:regulation of developmental pigmentation; IGI:MGI.
DR   GO; GO:0010468; P:regulation of gene expression; IMP:MGI.
DR   GO; GO:0010559; P:regulation of glycoprotein biosynthetic process; IMP:MGI.
DR   GO; GO:0040008; P:regulation of growth; IMP:MGI.
DR   GO; GO:0046902; P:regulation of mitochondrial membrane permeability; IDA:HGNC-UCL.
DR   GO; GO:0051881; P:regulation of mitochondrial membrane potential; IDA:HGNC-UCL.
DR   GO; GO:0006808; P:regulation of nitrogen utilization; IGI:MGI.
DR   GO; GO:0043067; P:regulation of programmed cell death; IGI:MGI.
DR   GO; GO:0032880; P:regulation of protein localization; IMP:MGI.
DR   GO; GO:0031647; P:regulation of protein stability; IMP:MGI.
DR   GO; GO:0045069; P:regulation of viral genome replication; IDA:UniProtKB.
DR   GO; GO:0001836; P:release of cytochrome c from mitochondria; IDA:HGNC-UCL.
DR   GO; GO:0003014; P:renal system process; IMP:MGI.
DR   GO; GO:0034097; P:response to cytokine; IMP:MGI.
DR   GO; GO:0010332; P:response to gamma radiation; IMP:MGI.
DR   GO; GO:0051384; P:response to glucocorticoid; IDA:MGI.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IMP:MGI.
DR   GO; GO:0010039; P:response to iron ion; IEA:Ensembl.
DR   GO; GO:0002931; P:response to ischemia; IMP:MGI.
DR   GO; GO:0035094; P:response to nicotine; IEA:Ensembl.
DR   GO; GO:0006979; P:response to oxidative stress; IMP:MGI.
DR   GO; GO:0048545; P:response to steroid hormone; IMP:MGI.
DR   GO; GO:0009636; P:response to toxic substance; IMP:MGI.
DR   GO; GO:0010224; P:response to UV-B; IMP:MGI.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IDA:MGI.
DR   GO; GO:0046666; P:retinal cell programmed cell death; IMP:MGI.
DR   GO; GO:0048741; P:skeletal muscle fiber development; IMP:MGI.
DR   GO; GO:0014909; P:smooth muscle cell migration; IMP:MGI.
DR   GO; GO:0048536; P:spleen development; IMP:MGI.
DR   GO; GO:0048864; P:stem cell development; IMP:MGI.
DR   GO; GO:0070231; P:T cell apoptotic process; IDA:MGI.
DR   GO; GO:0030217; P:T cell differentiation; IMP:MGI.
DR   GO; GO:0033077; P:T cell differentiation in thymus; IMP:MGI.
DR   GO; GO:0043029; P:T cell homeostasis; IMP:MGI.
DR   GO; GO:0002360; P:T cell lineage commitment; IMP:MGI.
DR   GO; GO:0048538; P:thymus development; IMP:MGI.
DR   GO; GO:0001657; P:ureteric bud development; IMP:MGI.
DR   CDD; cd06845; Bcl-2_like; 1.
DR   FunFam; 1.10.437.10:FF:000006; Apoptosis regulator Bcl-2; 1.
DR   Gene3D; 1.10.437.10; Blc2-like; 1.
DR   InterPro; IPR013278; Apop_reg_Bcl2.
DR   InterPro; IPR036834; Bcl-2-like_sf.
DR   InterPro; IPR046371; Bcl-2_BH1-3.
DR   InterPro; IPR026298; Bcl-2_fam.
DR   InterPro; IPR002475; Bcl2-like.
DR   InterPro; IPR004725; Bcl2/BclX.
DR   InterPro; IPR020717; Bcl2_BH1_motif_CS.
DR   InterPro; IPR020726; Bcl2_BH2_motif_CS.
DR   InterPro; IPR020728; Bcl2_BH3_motif_CS.
DR   InterPro; IPR003093; Bcl2_BH4.
DR   InterPro; IPR020731; Bcl2_BH4_motif_CS.
DR   NCBIfam; TIGR00865; bcl-2; 1.
DR   PANTHER; PTHR11256:SF11; APOPTOSIS REGULATOR BCL-2; 1.
DR   PANTHER; PTHR11256; BCL-2 RELATED; 1.
DR   Pfam; PF00452; Bcl-2; 1.
DR   Pfam; PF02180; BH4; 1.
DR   PRINTS; PR01863; APOPREGBCL2.
DR   PRINTS; PR01862; BCL2FAMILY.
DR   SMART; SM00337; BCL; 1.
DR   SMART; SM00265; BH4; 1.
DR   SUPFAM; SSF56854; Bcl-2 inhibitors of programmed cell death; 1.
DR   PROSITE; PS50062; BCL2_FAMILY; 1.
DR   PROSITE; PS01080; BH1; 1.
DR   PROSITE; PS01258; BH2; 1.
DR   PROSITE; PS01259; BH3; 1.
DR   PROSITE; PS01260; BH4_1; 1.
DR   PROSITE; PS50063; BH4_2; 1.
DR   TreeFam; TF315834; -.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; Autophagy; Cytoplasm;
KW   Endoplasmic reticulum; Membrane; Mitochondrion;
KW   Mitochondrion outer membrane; Nucleus; Phosphoprotein; Reference proteome;
KW   Transmembrane; Transmembrane helix; Ubl conjugation.
FT   CHAIN           1..236
FT                   /note="Apoptosis regulator Bcl-2"
FT                   /id="PRO_0000143049"
FT   TRANSMEM        209..230
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   MOTIF           10..30
FT                   /note="BH4"
FT   MOTIF           90..104
FT                   /note="BH3"
FT   MOTIF           133..152
FT                   /note="BH1"
FT   MOTIF           184..199
FT                   /note="BH2"
FT   SITE            34..35
FT                   /note="Cleavage; by caspases"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         69
FT                   /note="Phosphothreonine; by MAPK8"
FT                   /evidence="ECO:0000250|UniProtKB:P10415"
FT   MOD_RES         70
FT                   /note="Phosphoserine; by MAPK8 and PKC"
FT                   /evidence="ECO:0000269|PubMed:9115213"
FT   MOD_RES         84
FT                   /note="Phosphoserine; by MAPK8"
FT                   /evidence="ECO:0000250|UniProtKB:P10415"
FT   VAR_SEQ         193..236
FT                   /note="DAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK -> VGAC
FT                   LVE (in isoform Beta)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000513"
FT   MUTAGEN         70
FT                   /note="S->A: Loss of phosphorylation. Unable to suppress
FT                   apoptosis."
FT                   /evidence="ECO:0000269|PubMed:9115213"
FT   CONFLICT        64
FT                   /note="D -> E (in Ref. 1; AAA37281/AAA37282)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        89
FT                   /note="V -> C (in Ref. 1; AAA37281/AAA37282)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   236 AA;  26407 MW;  80FDCFE78C735092 CRC64;
     MAQAGRTGYD NREIVMKYIH YKLSQRGYEW DAGDADAAPL GAAPTPGIFS FQPESNPMPA
     VHRDMAARTS PLRPLVATAG PALSPVPPVV HLTLRRAGDD FSRRYRRDFA EMSSQLHLTP
     FTARGRFATV VEELFRDGVN WGRIVAFFEF GGVMCVESVN REMSPLVDNI ALWMTEYLNR
     HLHTWIQDNG GWDAFVELYG PSMRPLFDFS WLSLKTLLSL ALVGACITLG AYLGHK
//
